Morgan Stanley’s Akari Therapeutics AKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4 Sell
3
-3
-50% -$4 ﹤0.01% 8052
2025
Q1
$7 Hold
6
﹤0.01% 8019
2024
Q4
$7 Sell
6
-2
-25% -$2 ﹤0.01% 7919
2024
Q3
$24 Buy
8
+2
+33% +$6 ﹤0.01% 7783
2024
Q2
$16 Hold
6
﹤0.01% 7755
2024
Q1
$11 Sell
6
-10
-63% -$18 ﹤0.01% 7756
2023
Q4
$50 Buy
+16
New +$50 ﹤0.01% 7656
2022
Q2
Sell
-277
Closed -$7K 7786
2022
Q1
$7K Hold
277
﹤0.01% 7491
2021
Q4
$8K Hold
277
﹤0.01% 7522
2021
Q3
$9K Sell
277
-34
-11% -$1.11K ﹤0.01% 7355
2021
Q2
$11K Buy
311
+30
+11% +$1.06K ﹤0.01% 7201
2021
Q1
$15K Sell
281
-10
-3% -$534 ﹤0.01% 6818
2020
Q4
$11K Buy
291
+5
+2% +$189 ﹤0.01% 6599
2020
Q3
$10K Buy
286
+240
+522% +$8.39K ﹤0.01% 6266
2020
Q2
$2K Buy
46
+22
+92% +$957 ﹤0.01% 6431
2020
Q1
$1K Sell
24
-26
-52% -$1.08K ﹤0.01% 6445
2019
Q4
$2K Sell
50
-19
-28% -$760 ﹤0.01% 6489
2019
Q3
$2K Buy
69
+19
+38% +$551 ﹤0.01% 6464
2019
Q2
$2K Sell
50
-3
-6% -$120 ﹤0.01% 6449
2019
Q1
$4K Buy
53
+42
+382% +$3.17K ﹤0.01% 6349
2018
Q4
$0 Hold
11
﹤0.01% 6586
2018
Q3
$1K Hold
11
﹤0.01% 6608
2018
Q2
$0 Hold
11
﹤0.01% 6654
2018
Q1
$0 Hold
11
﹤0.01% 6599
2017
Q4
$1K Sell
11
-429
-98% -$39K ﹤0.01% 6476
2017
Q3
$54K Buy
440
+429
+3,900% +$52.7K ﹤0.01% 5757
2017
Q2
$1K Hold
11
﹤0.01% 6494
2017
Q1
$3K Hold
11
﹤0.01% 6414
2016
Q4
$2K Hold
11
﹤0.01% 6374
2016
Q3
$2K Sell
11
-7
-39% -$1.27K ﹤0.01% 6357
2016
Q2
$5K Sell
18
-70
-80% -$19.4K ﹤0.01% 6210
2016
Q1
$18K Buy
+88
New +$18K ﹤0.01% 5944
2015
Q3
Hold
0
6599
2015
Q2
Hold
0
6633
2015
Q1
Hold
0
6540
2014
Q4
Hold
0
6556
2014
Q3
Hold
0
6559
2014
Q2
Hold
0
6505
2014
Q1
Hold
0
6463